1-161198401-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005099.6(ADAMTS4):c.227G>A(p.Gly76Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000092 in 1,608,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005099.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS4 | NM_005099.6 | c.227G>A | p.Gly76Asp | missense_variant | 1/9 | ENST00000367996.6 | NP_005090.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS4 | ENST00000367996.6 | c.227G>A | p.Gly76Asp | missense_variant | 1/9 | 1 | NM_005099.6 | ENSP00000356975 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000145 AC: 34AN: 233890Hom.: 0 AF XY: 0.0000623 AC XY: 8AN XY: 128316
GnomAD4 exome AF: 0.0000412 AC: 60AN: 1456306Hom.: 0 Cov.: 32 AF XY: 0.0000387 AC XY: 28AN XY: 724320
GnomAD4 genome AF: 0.000578 AC: 88AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000591 AC XY: 44AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.227G>A (p.G76D) alteration is located in exon 1 (coding exon 1) of the ADAMTS4 gene. This alteration results from a G to A substitution at nucleotide position 227, causing the glycine (G) at amino acid position 76 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at